Table 2. Genotype distributions in case and control groups.
Study | Case/control | case | control | Outcome | ORG(95% CI) | ||||
GG | GA | AA | GG | GA | AA | ||||
Riha(2005) | 103/190 | 52 | 44 | 7 | 130 | 52 | 8 | Increased risk | 2.01(1.27–3.19) |
Liu(2006) | 76/42 | 45 | 23 | 8 | 35 | 6 | 1 | Increased risk | 3.35(1.37–8.23) |
Popko(2008) | 102/77 | 73 | 29 | 0 | 59 | 18 | 0 | Increased risk | 1.28(0.66–2.51) |
Bushan(2009) | 104/103 | 74 | 22 | 8 | 90 | 10 | 3 | Increased risk | 2.70(1.35–5.42) |
2.38(1.22–4.64)* | |||||||||
Almpanidou(2012) | 220/319 | 118 | 83 | 19 | 221 | 84 | 14 | Increased risk | 1.90(1.35–2.65) |
Guan(2013) | 531/162 | 430 | 95 | 6 | 143 | 18 | 1 | Increased risk | 1.76(1.04–2.97) |
Li(2013) | 155/100 | 137 | 18 | 0 | 88 | 12 | 0 | No association | 0.95(0.44–2.04) |
Note: *mean an adjustment for HWE.